all report title image

GOUTY ARTHRITIS MARKET ANALYSIS

Gouty Arthritis Market, by Drug Class (NSAIDs, Corticosteroids, Colchicine, and Urate-lowering agents), by Gouty Type (Acute Gouty Arthritis and Chronic Gouty Arthritis) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI1368
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Gouty Arthritis MarketSize and Trends

High prevalence of associated chronic diseases to provide growth to gouty arthritis market

Other comorbidities such as hypertension is often associated with gout. As per study published in Journal of Rheumatology in 2014, around 75% of gouty arthritis patient were reported to be suffering from hypertension. Therefore patients suffering from chronic disease are at high risk of developing gouty arthritis .High prevalence of gouty arthritis is expected to drive the growth for global gouty arthritis market. According to study published in British Medical Journal in 2017, prevalence of gouty arthritis is 1% to 10% globally. Furthermore, factors such as increasing consumption of high protein food worldwide, linked with gouty arthritis and increasing awareness amongst people for early treatment of disease are the factors boosting growth of gouty arthritis market.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.